SIMULTANEOUS ESTIMATION OF AZITHROMYCIN AND CEFIXIME IN BULK AND PHARMACEUTICAL FORMULATION BY REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (RP-HPLC)
Usharani Gundala*, Chandrashekar Bonagiri , Devanna Nayakanti
Abstract
Azithromycin and Cefixime are both antibiotics drugs. As there is no
UV or HPLC method for the simultaneous estimation of Azithromycin
and Cefixime, a need was felt to develop the method for the analysis of
both drugs simultaneously. This work concerns with the development
and validation of a simple, specific and cost effective RP-HPLC
method for simultaneous estimation of Azithromycin and Cefixime in
bulk. In addition the developed method was applied to the suitable
combined tablet dosage form ie., Zifi-AZ. Chromatography was
carried on Kromasil C18 column with mobile phase comprising of Ortho Phosphoric Acid buffer and Methanol in the ratio of 70:30 v/v. The flow rate was
adjusted to 1ml/min with PDA detection at 292 nm. The retention times of Azithromycin and
cefixime were found to be 2.8 min, 3.9 min respectively and other replicate standard system
suitability parameters are within the limit and uniform. The different analytical parameters
such as accuracy, precision, linearity, robustness, limit of detection (LOD), limit of
quantification (LOQ) were determined according to the International Conference on
Harmonization (ICH) Q2B guidelines. The detector response was linear in the range of 0.5-
1.5 mg/ml., 0.4-1.2 mg/ml for Azithromycin and cefixime respectively. The proposed method
was successfully applied for the reliable quantification of active pharmaceuticals present in
the commercial formulations.
Keywords: Azithromycin, Cefixime, HPLC, Methanol, Ortho Phospharic Acid.
[Full Text Article]